What now on the CANVAS of diabetes medications with cardiovascular protection? Could metformin, pioglitazone, SGLT2 inhibitors and liraglutide complement each other to save lives?

Robert E.J. Ryder, Ralph A. Defronzo, Bob Ryder

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)89-92
Number of pages4
JournalBritish Journal of Diabetes and Vascular Disease
Volume17
Issue number3
DOIs
StatePublished - 2017

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this